Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8329005 | International Journal of Biological Macromolecules | 2018 | 6 Pages |
Abstract
Previous study revealed that Se-GP11 could exhibited its antitumor activity by improving the immune functions. 5-Fu, as a chemotherapeutic drugs, can kill many immune cells in addition to tumor cells. Accordingly, the enhanced antitumor and reduced toxicity of Se-GP11 on 5-Fu were estimated in this study. The results demonstrated that Se-GP11 could evidently increase the antitumor activity of 5-Fu. Furthermore, Se-GP11 could enhance the immune functions during the tumor inhibition process of 5-Fu for increasing the cytokines secretion (IL-2 and TNF-α) and immune organs weights. In addition, Se-GP11 could reduce the toxicity of 5-Fu on liver by improving the hematological and biochemical parameters and up-regulating the SOD activities and down-regulating the MDA levels. Taken together, the results indicated that Se-GP11 may develop as an auxiliary preparation to chemical antitumor drugs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Guanghua Mao, Qian Li, Chunmeng Deng, Yaqian Wang, Yangyang Ding, Weijie Zhang, Yao Chen, Ting Zhao, Fengfeng Wei, Liuqing Yang, Xiangyang Wu,